Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
CVS | NYSE | USD | Real-time | |
CVS | CBOE Canada | CAD | Real-time | |
CVS | BIVA | MXN | Delayed | |
CVS | Mexico | MXN | Delayed | |
1CVS | Milan | EUR | Real-time | |
CVS | Frankfurt | EUR | Delayed | |
CVS | TradeGate | EUR | Delayed | |
CVSCL | Santiago | CLP | Delayed | |
CVS | Santiago | USD | Delayed | |
CVSm | Buenos Aires | ARS | Delayed | |
CVSH34 | B3 | BRL | Delayed | |
CVS | Vienna | EUR | Real-time | |
CVS | Lima | USD | Delayed |
Period Ending: | 2024 30/06 |
2024 31/03 |
2023 31/12 |
2023 30/09 |
||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 90840 | 87983 | 93545 | 89487 | ||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||
Cost of Revenue, Total | 77851 | 75876 | 79937 | 76187 | ||||||||||||||||||||||||||||||
Gross Profit | 12989 | 12107 | 13608 | 13300 | ||||||||||||||||||||||||||||||
Total Operating Expenses | 88087 | 86106 | 90107 | 85969 | ||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||
Operating Income | 2753 | 1877 | 3438 | 3518 | ||||||||||||||||||||||||||||||
Interest Income (Expense), Net Non-Operating | - | - | - | - | ||||||||||||||||||||||||||||||
Gain (Loss) on Sale of Assets | - | - | - | - | ||||||||||||||||||||||||||||||
Other, Net | 416 | 297 | 733 | 499 | ||||||||||||||||||||||||||||||
Net Income Before Taxes | 2337 | 1580 | 2705 | 3019 | ||||||||||||||||||||||||||||||
Provision for Income Taxes | 569 | 456 | 658 | 754 | ||||||||||||||||||||||||||||||
Net Income After Taxes | 1768 | 1124 | 2047 | 2265 | ||||||||||||||||||||||||||||||
Minority Interest | 181 | 182 | 175 | 173 | ||||||||||||||||||||||||||||||
Equity In Affiliates | - | - | - | - | ||||||||||||||||||||||||||||||
U.S GAAP Adjustment | - | - | - | - | ||||||||||||||||||||||||||||||
Net Income Before Extraordinary Items | 1770 | 1113 | 2046 | 2261 | ||||||||||||||||||||||||||||||
Total Extraordinary Items | - | - | - | - | ||||||||||||||||||||||||||||||
Net Income | 1770 | 1113 | 2046 | 2261 | ||||||||||||||||||||||||||||||
Total Adjustments to Net Income | - | - | - | - | ||||||||||||||||||||||||||||||
Income Available to Common Excluding Extraordinary Items | 1770 | 1113 | 2046 | 2261 | ||||||||||||||||||||||||||||||
Dilution Adjustment | -5.19 | -1.96 | -9.98 | 3.5 | ||||||||||||||||||||||||||||||
Diluted Net Income | 1775.19 | 1114.96 | 2055.98 | 2257.5 | ||||||||||||||||||||||||||||||
Diluted Weighted Average Shares | 1259 | 1267 | 1293 | 1290 | ||||||||||||||||||||||||||||||
Diluted EPS Excluding Extraordinary Items | 1.41 | 0.88 | 1.59 | 1.75 | ||||||||||||||||||||||||||||||
DPS - Common Stock Primary Issue | 0.665 | 0.665 | 0.605 | 0.605 | ||||||||||||||||||||||||||||||
Diluted Normalized EPS | 1.21 | 0.8 | 1.42 | 1.51 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review